ProfileGDS5678 / 1428865_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 68% 68% 63% 64% 66% 68% 67% 66% 68% 68% 67% 69% 68% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.13368
GSM967853U87-EV human glioblastoma xenograft - Control 24.1525668
GSM967854U87-EV human glioblastoma xenograft - Control 33.7881663
GSM967855U87-EV human glioblastoma xenograft - Control 43.8024864
GSM967856U87-EV human glioblastoma xenograft - Control 53.9703966
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.1508368
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.1172867
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.0124166
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.1860468
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.1199468
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.1055967
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 34.3062969
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.1210268
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.042967